Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

计划入组 22 人 · 首次发布于 2009 年 11 月 5 日

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

计划入组 24 人 · 首次发布于 2002 年 12 月 10 日

Anti-cancer stem cell monoclonal antibodies (OncoMed)

Anti-cancer stem cell monoclonal antibodies(OncoMed Pharmaceuticals, Inc.)

FUNDACION ONCOSUR

Spain

Oncovir, Inc.

United States

Oncor Pharmaceuticals, LLC

United States

Adaptive Biotechnologies Integrates clonoSEQ MRD Testing into Flatiron Health's OncoEMR Platform

Flatiron Health Aims to Boost Clinical Trial Access Through Pragmatic Design and Technology

Aranscia Acquires Spesana to Enhance Precision Medicine Workflow Solutions